Wire Stories

Exabeam Opens Office in ‘Silicon Valley of Maharashtra’ Pune, India to Support Cloud Offering Demand

Led by industry veteran Ashish Pradhan, the site will soon be home to nearly 60…

Hyosung Chairman Cho Hyun-joon to Strengthen Key Businesses in the U.S. Market

SEOUL, South Korea--(BUSINESS WIRE)--#AromaticAmide--Hyosung Chairman Cho Hyun-joon is gearing up to expand the company’s key…

Exabeam Opens Office in ‘Silicon Valley of Maharashtra’ Pune, India to Support Cloud Offering Demand

Led by industry veteran Ashish Pradhan, the site will soon be home to nearly 60…

First Fully Automated Terminal in Australia – Victoria International Container Terminal – Continues to Deliver Operational Excellence with Navis N4 Upgrade

OAKLAND, Calif.--(BUSINESS WIRE)--Navis, the provider of operational technologies and services that unlock greater performance and…

LEADING CHILD EDUCATIONAL HEALTH AND ACTIVITY SERVICES PROVIDER SELECTS DATA443 PRODUCT SUITE TO PROTECT AND PROVIDE PRIVACY COMPLIANCE SERVICES

Highly-sensitive data and large volumes drive complex requirements – millions of identities across over 24,000…

XPeng Launches New P5 Smart Family Sedan at RMB157,900 to RMB223,900

LiDAR-equipped third production model is smartest in its class Redefines family sedan, popularizing smart EVs…

Thales Partners with EVERING to Secure the Next-Generation of Wearable Fashion in Japan

EVERING, a fast-growing Japanese FinTech startup, launches its NFC ring, bringing the convenience of contactless…

Air Premia Partners with Navitaire

SEOUL, South Korea & MINNEAPOLIS--(BUSINESS WIRE)--#airpremia--Air Premia today announces it has selected Navitaire as its…

Tradeweb Partners with CFETS to Launch Southbound Bond Connect Extending China Footprint

New trading channel provides mainland Chinese investors with streamlined access to offshore fixed income markets…

U.S. FDA Grants BRUKINSA® (Zanubrutinib) Accelerated Approval in Relapsed or Refractory Marginal Zone Lymphoma

This marks the third FDA approval for BRUKINSA and first approval in marginal zone lymphoma…